Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Murthy

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Diabetologia|September 29, 2016
A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in miceCamille Attané, Marie-Line Peyot, Roxane Lussier, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 25, 2024
Silencing ANGPTL8 reduces mouse preadipocyte differentiation and insulin signalingAnindya Ghosh, Yat Hei Leung, Jeffrey Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2007
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosisMai Nguyen, Richard C Marcellus, Anne Roulston, et al.
Cell Reports|March 22, 2016
α/β-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 DiabetesShangang Zhao, Yves Mugabo, Gwynne Ballentine, et al.
JCI Insight|November 17, 2020
Adipose ABHD6 regulates tolerance to cold and thermogenic programsPegah Poursharifi, Camille Attané, Yves Mugabo, et al.
Molecular Metabolism|August 31, 2025
Suppression of adipocyte ABHD6 favors anti-inflammatory and adipogenic programs to preserve adipose tissue fitness in obesityPegah Poursharifi, Camille Attané, Isabelle Chenier, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Non-enzymatic ABHD6 interacts with Akt-FoxO1 axis to regulate selective hepatic insulin resistanceGuannan Li, Laurence T Maeyens, Jiyuan Yin, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular CarcinomaDanny Orabi, William J Massey, Kevin K Fung, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Diabetologia|September 29, 2016
A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in miceCamille Attané, Marie-Line Peyot, Roxane Lussier, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 25, 2024
Silencing ANGPTL8 reduces mouse preadipocyte differentiation and insulin signalingAnindya Ghosh, Yat Hei Leung, Jeffrey Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2007
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosisMai Nguyen, Richard C Marcellus, Anne Roulston, et al.
Cell Reports|March 22, 2016
α/β-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 DiabetesShangang Zhao, Yves Mugabo, Gwynne Ballentine, et al.
JCI Insight|November 17, 2020
Adipose ABHD6 regulates tolerance to cold and thermogenic programsPegah Poursharifi, Camille Attané, Yves Mugabo, et al.
Molecular Metabolism|August 31, 2025
Suppression of adipocyte ABHD6 favors anti-inflammatory and adipogenic programs to preserve adipose tissue fitness in obesityPegah Poursharifi, Camille Attané, Isabelle Chenier, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Non-enzymatic ABHD6 interacts with Akt-FoxO1 axis to regulate selective hepatic insulin resistanceGuannan Li, Laurence T Maeyens, Jiyuan Yin, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular CarcinomaDanny Orabi, William J Massey, Kevin K Fung, et al.
Pageof 15